Physician
Baton Rouge Clinic, a Medical Corporation
Baton Rouge Clinic, a Medical Corporation was paid $10.26M by Medicaid between Jan 2018 and Dec 2024, across 112 billing codes. Its largest line is 99232, hospital visit by a doctor, follow-up day — 31% of everything it billed.
33Billing provider infoBATON ROUGE CLINIC, A MEDICAL CORPORATION
BATON ROUGE, LA 70808
BATON ROUGE, LA 70808
33aNPI1871546911assigned 05/18/2006
33bProvider typePediatrics Physician
28Total paid$10.26M
24GClaims590,912
24DCodes billed112
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Louisiana
Rank by total paid#11 of 230
Median peer was paid$429K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,837 | $20K | |
| 2019 | 72,067 | $919K | |
| 2020 | 99,152 | $1.52M | |
| 2021 | 107,609 | $1.93M | |
| 2022 | 103,911 | $1.88M | |
| 2023 | 104,010 | $2.04M | |
| 2024incomplete | 102,326 | $1.94M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 31% | 133,486 | 43,071 | $3.20M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 12% | 34,022 | 16,174 | $1.19M |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 9.4% | 120,545 | 60,333 | $964K |
| 99223 | Prolong inpt eval add15 m | 8.6% | 14,798 | 12,868 | $885K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.3% | 28,631 | 24,617 | $745K |
| 99308 | Subsequent nursing facility care, per day, straightforward | 7.0% | 125,898 | 56,451 | $719K |
| 99239 | Hospital discharge day management, more than 30 minutes | 5.8% | 16,927 | 14,771 | $596K |
| 90792 | Psychiatric diagnostic evaluation with medical services | 4.9% | 9,998 | 8,001 | $505K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.8% | 18,694 | 15,665 | $394K |
| 99222 | Initial hospital care, per day, moderate complexity | 3.4% | 7,397 | 6,375 | $346K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 1.8% | 16,381 | 6,854 | $182K |
| 99220 | <1% | 1,065 | 905 | $49K |
100 more codes
| 95819 | <1% | 808 | $38K | |
| 99307 | <1% | 5,911 | $32K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,145 | $30K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 470 | $30K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 743 | $29K |
| 80053 | Comprehensive metabolic panel | <1% | 4,415 | $29K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,162 | $27K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 4,006 | $25K |
| 80061 | Lipid panel | <1% | 3,020 | $24K |
| 99221 | <1% | 378 | $18K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 832 | $17K |
| 36415 | Collection of venous blood by venipuncture | <1% | 14,034 | $15K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 647 | $15K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,590 | $13K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 503 | $11K |
| 90686 | <1% | 805 | $11K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,251 | $9K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,452 | $9K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 168 | $8K |
| 0001A | <1% | 426 | $8K | |
| 99348 | <1% | 449 | $8K | |
| 0002A | <1% | 403 | $8K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 90 | $7K |
| 99051 | <1% | 337 | $6K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 352 | $5K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 95 | $5K |
| 99407 | <1% | 446 | $4K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 283 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 773 | $3K |
| 90732 | <1% | 37 | $3K | |
| 93000 | <1% | 269 | $3K | |
| 0012A | <1% | 134 | $2K | |
| 99285 | Emergency room visit (most serious) | <1% | 30 | $2K |
| 0011A | <1% | 151 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 210 | $2K |
| 80050 | General health panel | <1% | 82 | $2K |
| 99226 | <1% | 68 | $2K | |
| 99283 | Emergency room visit (moderate) | <1% | 52 | $1K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 83 | $1K |
| 82728 | <1% | 143 | $1K | |
| 0003A | <1% | 100 | $1K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 25 | $1K |
| 73630 | <1% | 472 | $1K | |
| 99406 | <1% | 226 | $1K | |
| 99349 | <1% | 19 | $1K | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 180 | $1K |
| 81001 | <1% | 473 | $982.64 | |
| 83550 | <1% | 151 | $977.34 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 81 | $964.60 |
| 99347 | <1% | 83 | $958.98 | |
| 0004A | <1% | 67 | $879.56 | |
| 82043 | <1% | 186 | $736.63 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 28 | $707.40 |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 42 | $699.53 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 27 | $679.33 |
| 82570 | <1% | 186 | $657.46 | |
| 83540 | <1% | 164 | $648.42 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 27 | $631.58 |
| 87634 | <1% | 122 | $624.00 | |
| 20610 | <1% | 26 | $521.81 | |
| 0072A | <1% | 13 | $402.99 | |
| 0064A | <1% | 38 | $378.72 | |
| 99310 | Prolong nursin fac eval 15m | <1% | 37 | $350.63 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 530 | $323.71 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 58 | $315.04 |
| 95886 | <1% | 181 | $283.28 | |
| 99305 | <1% | 49 | $279.72 | |
| 96380 | <1% | 24 | $262.48 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 14 | $205.32 |
| 99318 | <1% | 129 | $200.33 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 66 | $186.87 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 18 | $175.44 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 56 | $141.79 |
| 81003 | <1% | 137 | $139.75 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 41 | $136.12 |
| 91300 | <1% | 563 | $112.49 | |
| 0124A | <1% | 12 | $110.34 | |
| 11721 | <1% | 29 | $108.70 | |
| 90474 | <1% | 29 | $73.04 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 71 | $30.03 |
| 90656 | <1% | 420 | $22.35 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 944 | $15.75 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 47 | $6.91 |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 823 | $4.79 |
| 90677 | <1% | 133 | $0.02 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 485 | $0.00 |
| 3044F | 0% | 474 | $0.00 | |
| 99217 | 0% | 28 | $0.00 | |
| 90647 | 0% | 56 | $0.00 | |
| 90723 | 0% | 33 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 25 | $0.00 |
| 91301 | 0% | 170 | $0.00 | |
| 91307 | 0% | 39 | $0.00 | |
| 99000 | 0% | 24 | $0.00 | |
| 90461 | 0% | 149 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 215 | $0.00 |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 23 | $0.00 |
| 99072 | 0% | 840 | $0.00 | |
| 96160 | 0% | 95 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSILVEY, EDGAR (C.E.O.)